Latest News in the pharma Industry

Market News

Merck launches new gene editing technology to engineer virus resistant CHO cell lines

Merck launches new gene editing technology to engineer virus resistant CHO cell lines

8 Sep 2016

Enhances viral safety while maintaining cell line productivity, protein quality.

Read more 
Dipexium Pharmaceuticals announces issuance of Locilex patent by EU

Dipexium Pharmaceuticals announces issuance of Locilex patent by EU

8 Sep 2016

Patent claims are directed to a novel formulation of Locilex, a topical antimicrobial peptide formulated as a topical cream, and the use of Locilex as a method of treating skin or wound infections.

Read more 
AGC acquires a leading German biopharmaceutical CMO

AGC acquires a leading German biopharmaceutical CMO

8 Sep 2016

The acquisition will generate a new and strong international microbial CMO, offering the complete services from process development to large-scale market supply.

Read more 
Demand for Aquila BioMedica's specialist CRO services accelerates company expansion

Demand for Aquila BioMedica's specialist CRO services accelerates company expansion

7 Sep 2016

Company's immuno-oncology and histology services have allowed clients' go/no-go decisions to be made earlier in the drug development process and ultimately reduce clinical attrition.

Read more 
OrthoSera receives CE Marking for hypACT device to regenerate osteoarthritic bone

OrthoSera receives CE Marking for hypACT device to regenerate osteoarthritic bone

7 Sep 2016

Patent and market authorization for human hyperacute serum product.

Read more 
BlueWind Medical receives CE Marking for its miniature implanted wireless stimulator to treat PNP

BlueWind Medical receives CE Marking for its miniature implanted wireless stimulator to treat PNP

7 Sep 2016

The BlueWind VIVENDI System is a wireless, battery-less neurostimulator which is 90% smaller than typical neurostimulators in the market.

Read more 
Non-drug device reduces COPD exacerbations - real-world study presented at ERS

Non-drug device reduces COPD exacerbations - real-world study presented at ERS

7 Sep 2016

The Aerobika device demonstrated a clinically-significant reduction in exacerbations in as little as 30 days of treatment, when used as an add-on to usual COPD medications.

Read more 
Apricus Biosciences launches its novel topical treatment for erectile dysfunction in Portugal, Ireland and Poland

Apricus Biosciences launches its novel topical treatment for erectile dysfunction in Portugal, Ireland and Poland

7 Sep 2016

To be Commercialized in Portugal and Ireland as Vitaros and in Poland as Vytaros.

Read more 
Ajaz Hussain and Wuxi Apptec’s Dr Minzhang Chen join 12 strong CPhI Annual Industry report experts

Ajaz Hussain and Wuxi Apptec’s Dr Minzhang Chen join 12 strong CPhI Annual Industry report experts

6 Sep 2016

2016 report topics include 3D printing, FDA quality metrics, contract services, pharma growth in China and India, and generic licensing.

Read more 
Avara acquires AstraZeneca UK manufacturing facility

Avara acquires AstraZeneca UK manufacturing facility

6 Sep 2016

The plant will continue to manufacture critical AstraZeneca pharmaceutical products on a contract basis.

Read more 
Aptar Pharma hosts “The Nasal drug Delivery Journey: From Systemic to Nose-to-Brain scientific webinar

Aptar Pharma hosts “The Nasal drug Delivery Journey: From Systemic to Nose-to-Brain" scientific webinar

6 Sep 2016

Webinar will focus on the nasal drug delivery route in the treatment of central nervous system diseases.

Read more 
Cambrex to expand large-scale API manufacturing at its Karlskoga facility in Sweden

Cambrex to expand large-scale API manufacturing at its Karlskoga facility in Sweden

6 Sep 2016

The investment includes the installation of new multi-purpose reactors and upgrading of the control room within an existing plant on site.

Read more